Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization
Do DV, Bressler SB, Cassard SD, Gower EW, Tabandeh H, Jefferys JL, Bressler NM. Retina. 2014 Oct;34(10):2063-71.
Do DV, Bressler SB, Cassard SD, Gower EW, Tabandeh H, Jefferys JL, Bressler NM. Retina. 2014 Oct;34(10):2063-71.